Editorial
Treatment of prostate and renal cancer with oral drugs (abiratarone and antiangiogenic agents): Positioning statement from the Spanish Association of Urology
Tratamiento del cáncer de próstata y cáncer renal con fármacos orales (abiraterona y antiangiogénicos): posicionamiento de la Asociación Española de Urología
H. Villavicencio, C. Hernández, A. Gómez, J.M. Cózar, A. Rodríguez-Antolín, L. Prieto, M. de Cabo, J.M. Malet, J. Extramiana, J. Mata, M. Arrabal, G. Server, E. Solsona, J.I. del Valle, E. Miguélez, E. Gutiérrez, A. Elizalde, J. Mateos, J.L. Artiles, M. Jiménez-Cidre..., L.M. Nalda, N. Cruz, M. Ozonas, J. Caffaratti, M. Esteban, M. Unda, C. Reina, J.L. Álvarez-Ossorio, E. Lledó, J.C. Angulo
Ver más
Corresponding author
Junta Directiva, Asociación Española de Urología (AEU)
Read
852
Timeswas read the article
228
Total PDF
624
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2018 2 | 20 | 1 | 21 |
| 2018 1 | 13 | 1 | 14 |
| 2017 12 | 22 | 1 | 23 |
| 2017 11 | 11 | 2 | 13 |
| 2017 10 | 5 | 3 | 8 |
| 2017 9 | 8 | 7 | 15 |
| 2017 8 | 14 | 4 | 18 |
| 2017 7 | 7 | 3 | 10 |
| 2017 6 | 10 | 11 | 21 |
| 2017 5 | 9 | 1 | 10 |
| 2017 4 | 22 | 2 | 24 |
| 2017 3 | 15 | 36 | 51 |
| 2017 2 | 16 | 3 | 19 |
| 2017 1 | 10 | 1 | 11 |
| 2016 12 | 22 | 11 | 33 |
| 2016 11 | 26 | 7 | 33 |
| 2016 10 | 39 | 11 | 50 |
| 2016 9 | 18 | 6 | 24 |
| 2016 8 | 12 | 2 | 14 |
| 2016 7 | 12 | 1 | 13 |
| 2016 6 | 20 | 8 | 28 |
| 2016 5 | 19 | 12 | 31 |
| 2016 4 | 27 | 9 | 36 |
| 2016 3 | 19 | 13 | 32 |
| 2016 2 | 28 | 11 | 39 |
| 2016 1 | 24 | 11 | 35 |
| 2015 12 | 24 | 12 | 36 |
| 2015 11 | 19 | 8 | 27 |
| 2015 10 | 17 | 2 | 19 |
| 2015 9 | 13 | 3 | 16 |
| 2015 8 | 13 | 4 | 17 |
| 2015 7 | 9 | 5 | 14 |
| 2015 6 | 14 | 1 | 15 |
| 2014 7 | 1 | 0 | 1 |
| 2014 5 | 1 | 1 | 2 |
| 2014 2 | 2 | 0 | 2 |
| 2014 1 | 6 | 0 | 6 |
| 2013 12 | 21 | 2 | 23 |
| 2013 11 | 25 | 6 | 31 |
| 2013 10 | 11 | 6 | 17 |
Show all
